uniQure (QURE) Amortizatization of Intangibles (2023 - 2026)
uniQure (QURE) posted quarterly Amortizatization of Intangibles of -$3.6 million for Q2 2026, down 74.58% year-over-year from -$14.1 million in Q2 2025, and up 17.6% quarter-over-quarter from -$4.3 million in Q1 2026.
Analysis
uniQure (QURE) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
uniQure's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$3.6 million for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 74.58% year-over-year to -$3.6 million; the TTM figure through Jun 2026 stood at -$14.2 million (down 69.29% YoY), while the FY2025 annual figure was -$10.5 million, up 4.02% from the prior year.
- Amortizatization of Intangibles for Q2 2026 stood at -$3.6 million, up from -$4.3 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was -$912000.0 in Q2 2023, with the low at -$4.7 million in Q3 2023.
- The 4-year median for Amortizatization of Intangibles is -$2.7 million (2024), against an average of -$2.9 million.
- Peak annual rise in Amortizatization of Intangibles reached 61.64% in 2024, while the deepest fall reached 299.46% in 2024.
- uniQure's Amortizatization of Intangibles stood at -$4.4 million in 2023, then surged by 44.64% to -$2.4 million in 2024, then sank by 79.99% to -$4.4 million in 2025, then grew by 18.3% to -$3.6 million in 2026.
- Business Quant data shows QURE's Amortizatization of Intangibles at -$3.6 million in Q2 2026, -$4.3 million in Q1 2026, and -$4.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -3.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.57 Mn |
| Mar 31, 2026 | -4.34 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | -4.39 Mn |
| Sep 30, 2023 | -4.69 Mn |
| Jun 30, 2023 | -912,000.00 |
| Mar 31, 2023 | -925,000.00 |